Health Care · Services-Offices & Clinics of Doctors of Medicine

SBC SBC Medical Group Holdings Inc SEC Filings & Insider Trading Activity 2026

company
CIK 193031341 filings
Russell 2000

SBC at a glance

SBC Medical Group Holdings Inc (SBC, SEC CIK 1930313) filed its latest 10-K annual report on March 27, 2026, a 10-Q quarterly report on November 13, 2026, an 8-K current report on November 19, 2026 and Form 4 insider filings as recently as April 29, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), SBC Medical Group Holdings Inc (SBC) reported revenue of $173.6 million (down 15.5% from FY2024) and net income of $51.0 million. Diluted EPS was $0.50.
  • As of September 30, 2026, 18 institutional investment managers tracked by SignalX reported holding SBC Medical Group Holdings Inc (SBC) shares worth $9.7 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Aikawa Yoshiyuki on April 28, 2026 of 465,000 shares at $3.02 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$173.6M
−15.5% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
18 funds
$9.7M · +2 vs prior quarter
Latest 8-K
Nov 19, 2026
Item 8.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New Nasdaq compliance risk: independent director departure triggered board and audit committee violations on July 8, 2026
  • Most material update: delisting risk, Nasdaq cure period runs through July 9, 2027
  • Regulatory risk: delisting could reduce liquidity and classify common stock as a penny stock
  • Operational risk: failure to appoint independent directors could prevent restored Nasdaq compliance
  • Financial risk: delisting could decrease ability to issue securities or obtain future financing

Management Discussion & Analysis

  • Quarterly revenue $58.6M, up 35.13% YoY from $43.4M
  • Operating margin 45.09% vs 36.63% YoY, net income margin 26.79% vs 29.58%
  • Best line management services revenue $16.4M, up 73.28%; weakest franchising revenue $9.6M, down 3.60%
  • Cash $198.4M vs $163.8M at December 31, 2025; operating cash flow $50.2M vs $(27.3)M
  • Capital deployment: $8.9M borrowing repayments, $5.0M investment commitment, no share repurchases under $20.0M authorization

AI summary of the SBC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 19, 2026Full analysis →

Item 8.01: Other Events

  • Cybersecurity incidents occurred in Japan on November 16, 2026
  • Potential effects on business, financial condition and results remain undetermined

Item EX-99.1: Item EX-99.1

  • Cyberattack exposed customer databases, affecting 1,624,000 basic records and additional reservation, inquiry, treatment-monitor, and review data
  • Employee data compromised, including approximately 20,000 account records and sensitive employment information for 459 employees
Filed Nov 13, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Press release announces SBC Medical Group Holdings’ quarterly results for the period ended September 30, 2026
  • Exhibit 99.1 contains the financial results and management commentary investors need for performance assessment

Item 7.01: Regulation FD Disclosure

  • Investor presentation covers 3Q 2026 results for quarter ended September 30, 2026
  • Presentation posted November 13, 2026 at SBC Medical Group’s investor-relations website

Item EX-99.1: Item EX-99.1

  • 3Q26 revenue $59 million, up 35%, driven by higher management fees, service-fee revisions and Waqoo consolidation
  • Operating income $26 million, up 66%, with 45% margin, indicating substantial operating leverage
Filed Aug 13, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 revenue $49M, up 13% YoY, signaling growth reacceleration after 2025 restructuring
  • Net income attributable to SBC Medical $11M, up 335%, with margin expanding to 22% from 6%

Item 2.02: Results of Operations and Financial Condition

  • Exhibit 99.1 announces SBC Medical Group Holdings’ results for the quarter ended June 30, 2026
  • Quarterly financial figures and management commentary are contained in the attached earnings release

Item 7.01: Regulation FD Disclosure

  • 2Q 2026 investor presentations posted August 13, 2026
  • Materials cover business overview and results for quarter ended June 30, 2026

AI summaries of SBC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for SBC

Don't miss the next SBC filing

  • Alerts as it files. A push when SBC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut SBC, by share count.
  • Ask anything. An AI agent that reads every SBC filing and answers with sources.

SBC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Aikawa YoshiyukiSellApr 28, 2026$3.02
Aikawa YoshiyukiSellApr 21, 2026$3.02
Aikawa YoshiyukiSellMar 6, 2026$2.12
Aikawa YoshiyukiJMar 6, 2026-
Aikawa YoshiyukiJMar 6, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$205.4M$173.6M
Gross Profit-$156.1M$127.3M
Operating Income-$70.3M$67.5M
Net Income-$46.6M$51.0M
Gross Margin-76.0%73.3%
Op. Margin-34.2%38.9%
Net Margin-22.7%29.4%
Balance Sheet
Total Assets-$266.1M$380.4M
Equity-$6.0M$195.1M$248.3M
ROE-23.9%20.5%
Per Share
EPS$0.42$0.48$0.50
Cash Flow
Operating CF-$20.6M$24.7M
CapEx-$2.6M$1.4M

Source: XBRL data in SBC Medical Group Holdings Inc (SBC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate SBC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
SBC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202618$9.7M
Q2 202616$5.1M
Q1 202614$3.4M
Q4 202513$3.8M
Q3 202512$2.3M
Q2 202511$1.9M
Q1 20251$3,000
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 85 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

SBC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 19, 2026Analysis-
8-KNov 13, 2026Analysis-
10-QNov 13, 2026Analysis
10-QAug 13, 2026Analysis
8-KAug 13, 2026Analysis-
8-KJul 14, 2026Analysis-
8-KMay 20, 2026Analysis
8-KMay 14, 2026Analysis
10-QMay 14, 2026Analysis
4Apr 29, 2026--
4Apr 23, 2026--
8-KApr 23, 2026Analysis-
10-KMar 27, 2026-
8-KMar 27, 2026--
SC 13GMar 13, 2026-
4Mar 10, 2026--
8-KJan 5, 2026-
8-KDec 31, 2025-
8-KDec 15, 2025-
10-QNov 14, 2025Analysis
10-QAug 13, 2025-
10-QMay 15, 2025-
10-KMar 28, 2025Analysis
10-QNov 13, 2024-
SC 13DSep 23, 2024-

Related Health Care companies

All Health Care →

SBC SEC filings: frequently asked questions

Which institutions hold SBC stock?

As of September 30, 2026, the largest SBC Medical Group Holdings Inc (SBC) holders among the 13F filers tracked by SignalX were BlackRock ($5.3 million), Vanguard Capital Management LLC ($1.0 million), Northern Trust ($724,000), Vanguard Portfolio Management LLC ($650,000), State Street Corp ($386,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was SBC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), SBC Medical Group Holdings Inc (SBC) reported revenue of $173.6 million (down 15.5% from FY2024) and net income of $51.0 million. Diluted EPS was $0.50. The figures come from the XBRL data in the 10-K.

What did SBC report in its latest 8-K?

SBC Medical Group Holdings Inc (SBC) filed an 8-K on November 19, 2026 reporting Item 8.01 (Other Events). Cybersecurity incidents occurred in Japan on November 16, 2026.

What are the latest SBC SEC filings?

SBC Medical Group Holdings Inc (SBC) filed its latest 10-K annual report on March 27, 2026, a 10-Q quarterly report on November 13, 2026, an 8-K current report on November 19, 2026 and a Form 4 insider filing on April 29, 2026.

What is SBC's SEC CIK number?

SBC Medical Group Holdings Inc (SBC)'s SEC Central Index Key (CIK) is 1930313. EDGAR lists every SBC filing under that number.

Ask anything about SBC

The research agent reads SBC's filings, financials, insider trades and 13F holders, then answers with sources.